Human RPL13A ELISA Kit Size:96T as it enhances RPA's binding

as it enhances RPA's binding affinity to ssDNA and promotes the recruitment of Rad51

HMGA1a and HMGA1b

and produces NO as an immune defense mechanism

Inhibitors targeting FLT3 have been developed as potential therapeutic agents for AML and other hematologic malignancies

Human RPL13A ELISA Kit Size:96T as it enhances RPA's bindingProduct Specification Usage Required experimental equipment: 1. Microplate reader (450nm) 2. High precision pipettes and pipette tips: 0. 5 10uL, 5 50uL, 20 200uL, 200 1000uL 3. 37C incubator 4. Distilled or deionized water Sample preparation and requirements: Tissue homogenization: Rinse the tissue with pre chilled PBS (0. 01M, pH 7. 4) to remove residual blood (lysed red blood cells in the homogenate will affect the measurement results). Weigh and